Want to join the conversation?
$BCR's 3Q15 sales from surgical graft were up 4% in 3Q15. The Endovascular business sales grew 18%, excluding the royalty payment from Gore. Within the Endovascular business, biopsy products climbed 14%, driven by healthy growth across the U.S. and even better performance internationally.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.